| Dr Marc Tubay, MD | |
|
Raf Lakenheath 48 Mdg/sghc, Unit 5115, Apo, AE 09461-5115 | |
| (314) 226-8124 | |
| Not Available |
| Full Name | Dr Marc Tubay |
|---|---|
| Gender | Male |
| Speciality | Radiology - Diagnostic Radiology |
| Location | Raf Lakenheath 48 Mdg/sghc, Apo, Armed Forces Europe |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346428513 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Marc Tubay, MD 4102 Pinion Dr, Usaf Academy, CO 80840-2502 Ph: (719) 333-5171 | Dr Marc Tubay, MD Raf Lakenheath 48 Mdg/sghc, Unit 5115, Apo, AE 09461-5115 Ph: (314) 226-8124 |
News Archive
GE Healthcare, a leading provider of information technology systems across the globe, is announcing an agreement to provide state-of-the-art healthcare information technology to one of the nation's most impoverished areas.
Oncolytics Biotech Inc. has announced that it has received a letter of approval from the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) for its Clinical Trial Application (CTA) to begin a clinical trial using intravenous administration of REOLYSIN in combination with cyclophosphamide, a chemotherapeutic agent as well as immune modulator, in patients with advanced cancers.
Synthetic collagen has a wide range of applications in reconstructive and cosmetic surgery and in the food industry. For proper function in animals a certain number of prolines within the protein need to be hydroxylated. BioMed Central's open access journal BMC Biotechnology reports that for the first time the α1 chain of type 1 collagen has been produced in maize with similar levels of proline hydroxylation to human collagen.
New International Health Regulations (IHR)-designed to halt the international spread of dangerous diseases and other threats-are now in force, with the chief aim of reducing the time it takes to identify an illness or other public health threat-including chemical and radiological hazards-that could have an international impact, in order to mobilize a more timely and effective response.
Appearing in Lancet Oncology, long term results of EORTC trial 22921 with 10.4 years median follow-up show that 5-FU (fluorouracil) based adjuvant chemotherapy after preoperative (chemo)-radiotherapy for patients with cT3-resectable T4 M0 rectal cancer does not improve survival or disease-free survival.
› Verified 3 days ago
Dr. Shahin Nassirkhani, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: Unit 33100, Apo, AE 09180 Phone: 314-590-6986 | |
Dr. Grayson W Hooper, D.O. Radiology Medicare: Not Enrolled in Medicare Practice Location: Landstuhl Regional Medical Center, Unit 33100, Apo, AE 09180 Phone: 314-590-7815 | |
Dr. Scott Dwane Myers Jr., MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 48th Mdg, Unit 5115, Apo, AE 09461 Phone: 314-226-8010 | |
Dr. Nicolas Ray Cahanding, DO Radiology Medicare: Not Enrolled in Medicare Practice Location: Unit 33100, Apo, AE 09180 Phone: 314-590-7805 | |
Joseph Sarette, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: Landstuhl Regional Medical Center, Unit 33100, Apo, AE 09180 Phone: 314-590-6042 | |
Mrs. Erin Rosa Moore-preston, RTR Radiology Medicare: Not Enrolled in Medicare Practice Location: Us Army Medical Activity- Bavaria, Unit 28038, Apo, AE 09112 Phone: 637-194-6439 |